Crescent Biopharma Grants 16,950 Share Options at $21.47 Strike Price
CBIO•Crescent Biopharma granted inducement awards of options for 16,950 ordinary shares to two non-executive employees under the 2025 Employment Inducement Incentive Award Plan. The options carry a 10-year term at a $21.47 exercise price and vest 25% after one year with monthly vesting thereafter.
1. Grant Details
Crescent Biopharma’s Compensation Committee approved inducement awards granting options for 16,950 ordinary shares to two non-executive employees under the 2025 Employment Inducement Incentive Award Plan with a 10-year term and $21.47 exercise price.
2. Vesting Terms and Rule Compliance
Options vest 25% after the first anniversary of each employee’s start date and 1/48th monthly thereafter, subject to continuous service, and were approved in compliance with Nasdaq Listing Rule 5635(c)(4).
